BANK OF AMERICA CORP /DE/
BankPosition in SUPN — Supernus Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in SUPN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,887,451
-$8,030,888 QoQ
Shares Held
621,102
-13.0% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 335 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Derivatives in SUPN
reported options exposure · as of Mar 31, 2021CallValue
$395,318
CallShares
15,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $1,596,028,663 across 49 Drug Manufacturers - Specialty & Generic names. SUPN ranks #14 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,924,926 | $282,045,178 | |
| 2 | LQDA |
Liquidia Corp
|
1,991,566 | $158,787,554 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,227,607 | $143,231,322 | |
| 4 | VTRS |
Viatris Inc
|
7,356,708 | $116,824,520 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
619,352 | $104,385,582 | |
| 6 | HLN |
Haleon plc
|
10,850,097 | $101,231,403 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
179,235 | $97,114,896 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
3,909,871 | $96,221,922 |
All Filings in SUPN
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,887,451 | 621,102 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $36,918,339 | 714,226 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $25,881,123 | 520,747 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $40,281,709 | 842,890 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $15,895,722 | 504,306 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,820,835 | 483,079 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $13,490,858 | 373,088 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,705,405 | 375,414 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,849,824 | 405,601 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,300,029 | 360,599 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,553,778 | 364,678 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $9,787,402 | 355,002 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $9,098,467 | 302,677 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $12,251,823 | 338,168 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $12,014,546 | 336,825 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $11,342,893 | 335,093 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,339,565 | 322,945 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $16,294,868 | 504,173 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $15,598,235 | 534,919 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $12,861,819 | 482,258 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,921,346 | 582,051 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $14,667,681 | 560,263 | Shares | Defined | 2021-05-14 | |
| 2021-03-31 | $395,318 | 15,100 | Call | Defined | 2021-05-14 | |
| 2020-12-31 | $13,305,939 | 528,853 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $12,444,082 | 597,125 | Shares | Defined | 2020-11-13 | |
| 2020-09-30 | $439,724 | 21,100 | Put | Defined | 2020-11-13 | |
| 2020-06-30 | $12,618,941 | 531,324 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,867,616 | 437,333 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||